Integrated ReportFiscal Year Ended Mar. 31, 2023

• Corporate Philosophy

Our Company

• Roundtable Discussion with the Chairperson of the Board, Executive Chairperson, and CEO
• Initiatives for Patient Safety and Growth
• Value Creation Model
• Steps toward Becoming a Truly Global MedTech Company
• Overview
• Message from the CFO
• Messages from Executive Officers

Our Strategy

• Our New Company Strategy
• ESG Strategy
• Global Healthcare Data
• Overview and Direction of Medical Business
• Endoscopic Solutions Business
• Therapeutic Solutions Business
• Customer Voices
• Infection Prevention
• Innovation
• Intellectual Property Activities
• Medical Business Strategy: Chinese Market
• Medical Business Strategy: Asian Emerging Markets
• Strategic M&A
• Care Pathway Enhancement
• Intelligent Endoscopy Ecosystem
• Evolving Our Corporate Culture
• Activities to Improve Productivity
• Carbon Neutral Society and Circular Economy
• Responsible Supply Chain

Our Setup

• Corporate Governance
• Directors
• Compliance
• Communication with Shareholders and Investors
• Risk Management

Data

• 10-Year Financial/Non-financial Data
• Corporate Information/Stock Information